Recent medical literature contains multiple articles alerting physicians to adverse events identified in patients taking the blockbuster drugs liraglutide (Victoza®) and semaglutide (Ozempic®, Wygovy®, Rybelsus®) for diabetes or weight loss. The undesirable effects reported include bowel obstruction, bowel paralysis, pancreatitis and suicidal ideation. If you take one of these drugs, how concerned should you be?
The post Side Effects of the New Diabetes/Weight Loss Medications appeared first on Heart Advisor.